Ellis Investment Partners, LLC Abbott Laboratories Transaction History

Ellis Investment Partners, LLC

$495 Million
Q4 2024

A detailed history of Ellis Investment Partners, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Ellis Investment Partners, LLC holds 4,207 shares of ABT stock, worth $552,968. This represents 0.1% of its overall portfolio holdings.

Number of Shares

4,207

Previous 4,199 0.19%

Holding current value

$552,968

Previous $478,000 0.63%

% of portfolio

0.1%

Previous 0.1%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 30, 2025	BUY	$111.93 - $119.39 $895 - $955	8 Added 0.19%	4,207 $475,000
Q3 2024 Oct 24, 2024	SELL	$100.07 - $118.13 $1,300 - $1,535	-13 Reduced 0.31%	4,199 $478,000
Q2 2024 Aug 06, 2024	SELL	$100.73 - $112.44 $17,527 - $19,564	-174 Reduced 3.97%	4,212 $437,000
Q1 2024 Apr 15, 2024	BUY	$109.52 - $120.96 $876 - $967	8 Added 0.18%	4,386 $498,000
Q4 2023 Jan 29, 2024	BUY	$90.19 - $110.4 $721 - $883	8 Added 0.18%	4,378 $481,000
Q3 2023 Nov 01, 2023	BUY	$95.53 - $114.62 $764 - $916	8 Added 0.18%	4,370 $423,000
Q2 2023 Aug 07, 2023	BUY	$100.78 - $112.29 $705 - $786	7 Added 0.16%	4,362 $475,000
Q1 2023 May 10, 2023	BUY	$96.86 - $114.01 $678 - $798	7 Added 0.16%	4,355 $440,000
Q4 2022 Jan 31, 2023	BUY	$95.06 - $111.52 $760 - $892	8 Added 0.18%	4,348 $477,000
Q3 2022 Nov 14, 2022	SELL	$96.76 - $112.03 $11,320 - $13,107	-117 Reduced 2.63%	4,340 $420,000
Q2 2022 Aug 01, 2022	BUY	$102.07 - $123.37 $714 - $863	7 Added 0.16%	4,457 $484,000
Q1 2022 May 03, 2022	SELL	$114.02 - $139.04 $46,748 - $57,006	-410 Reduced 8.44%	4,450 $526,000
Q4 2021 Feb 01, 2022	BUY	$115.53 - $141.46 $693 - $848	6 Added 0.12%	4,860 $684,000
Q3 2021 Oct 21, 2021	SELL	$116.66 - $129.06 $61,246 - $67,756	-525 Reduced 9.76%	4,854 $573,000
Q2 2021 Jul 26, 2021	BUY	$105.79 - $124.53 $317 - $373	3 Added 0.06%	5,379 $623,000
Q1 2021 May 03, 2021	SELL	$108.84 - $128.23 $75,099 - $88,478	-690 Reduced 11.37%	5,376 $644,000
Q4 2020 Jan 20, 2021	SELL	$105.0 - $114.42 $29,610 - $32,266	-282 Reduced 4.44%	6,066 $664,000
Q3 2020 Oct 19, 2020	SELL	$91.64 - $111.29 $52,967 - $64,325	-578 Reduced 8.35%	6,348 $690,000
Q2 2020 Jul 13, 2020	BUY	$76.57 - $98.0 $93,721 - $119,952	1,224 Added 21.47%	6,926 $634,000
Q1 2020 Apr 17, 2020	SELL	$62.82 - $91.86 $49,564 - $72,477	-789 Reduced 12.16%	5,702 $436,000
Q4 2019 Jan 07, 2020	BUY	$78.51 - $87.4 $942 - $1,048	12 Added 0.19%	6,491 $564,000
Q3 2019 Oct 09, 2019	SELL	$81.84 - $88.74 $7,283 - $7,897	-89 Reduced 1.36%	6,479 $530,000
Q2 2019 Jul 24, 2019	SELL	$72.88 - $85.0 $8,162 - $9,520	-112 Reduced 1.68%	6,568 $554,000
Q1 2019 Apr 25, 2019	SELL	$66.22 - $80.06 $34.9 Million - $42.2 Million	-527,351 Reduced 98.75%	6,680 $532,000
Q1 2019 Apr 24, 2019	BUY	$66.22 - $80.06 $35.4 Million - $42.8 Million	534,031 New	534,031 $534,000
Q1 2019 Apr 22, 2019	SELL	$66.22 - $80.06 $441,488 - $533,760	-6,667 Closed	0 $0
Q4 2018 Jan 29, 2019	BUY	$65.56 - $74.27 $437,088 - $495,158	6,667 New	6,667 $482,000

Others Institutions Holding ABT

# of Institutions

3,275

Shares Held

1.31B

Call Options Held

9.63M

Put Options Held

8.36M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $230B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ellis Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ellis Investment Partners, LLC with notifications on news.

Account

Ellis Investment Partners, LLC Abbott Laboratories Transaction History